(Q34063389)

30 July 2017

1 reference

title

Overview of the pharmacokinetics of fluvoxamine (English)

1 reference

30 July 2017

Overview of the Pharmacokinetics of Fluvoxamine (English)

0 references

1 reference

1 reference

van Harten J

1

1 reference

30 July 2017

Jaap van Harten

series ordinal

1

0 references

publication date

1 January 1995

1 reference

Clinical Pharmacokinetics

30 July 2017

1995

0 references

published in

1 reference

30 July 2017

29 Suppl 1

1 reference

30 July 2017

29

0 references

page(s)

1-9

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199500291-00003

30 July 2017

Supplement 1

0 references

exact match

0 references

cites work

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

1 reference

12 December 2020

Fluvoxamine-tricyclic antidepressant interaction

1 reference

12 December 2020

Review of the animal pharmacology and pharmacokinetics of fluvoxamine

1 reference

12 December 2020

Clinical pharmacokinetics of fluvoxamine

1 reference

12 December 2020

Excretion of fluvoxamine in breast milk

1 reference

12 December 2020

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

1 reference

12 December 2020

Drug interactions and the cytochrome P450 system. The role of cytochrome P450 2C19.

1 reference

12 December 2020

Clinical pharmacology and pharmacokinetics of fluoxetine: a review.

1 reference

12 December 2020

Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive function

1 reference

12 December 2020

Chronic treatment with fluvoxamine, clovoxamine, and placebo: interaction with digoxin and effects on sleep and alertness

1 reference

12 December 2020

Fluvoxamine and lithium: an unusual interaction

1 reference

12 December 2020

Pharmacokinetics of fluoxetine and fluvoxamine in depressed patients: personal results

1 reference

12 December 2020

Toxic Interaction Between Fluvoxamine and Sustained Release Theophylline in an 11-Year-Old Boy

1 reference

12 December 2020

Pharmacokinetics of fluvoxamine maleate after increasing single oral doses in healthy subjects

1 reference

12 December 2020

Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients

1 reference

12 December 2020

Bioavailability of fluvoxamine given with and without food

1 reference

12 December 2020

Inhibitors of imipramine metabolism by human liver microsomes

1 reference

12 December 2020

Pharmacokinetic optimisation of therapy with newer antidepressants

1 reference

12 December 2020

Interaction between fluvoxamine and imipramine/desipramine in four patients

1 reference

12 December 2020

Absorption of paroxetine under various dietary conditions and following antacid intake

1 reference

12 December 2020

Single and multiple oral dose fluvoxamine kinetics in young and elderly subjects

1 reference

12 December 2020

Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects

1 reference

12 December 2020

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

1 reference

12 December 2020

Inhibition of diazepam metabolism by fluvoxamine: a pharmacokinetic study in normal volunteers.

1 reference

12 December 2020

Carbamazepine coadministration with fluoxetine or fluvoxamine

1 reference

12 December 2020

The relationship between paroxetine and the sparteine oxidation polymorphism

1 reference

12 December 2020

A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine.

1 reference

12 December 2020

Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects

1 reference

12 December 2020

Pharmacokinetics of fluvoxamine maleate in patients with liver cirrhosis after single-dose oral administration

1 reference

12 December 2020

Increased trimipramine plasma levels during fluvoxamine comedication

1 reference

12 December 2020

Interaction between carbamazepine and fluvoxamine

1 reference

12 December 2020

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

12 December 2020

[Possible interaction between theophylline and fluvoxamine]

1 reference

12 December 2020

Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients

1 reference

12 December 2020

Fluvoxamine and chlorimipramine in endogenous depression

1 reference

12 December 2020

Fluvoxamine maleate: metabolism in man

1 reference

12 December 2020

Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

12 December 2020

Safety database on fluvoxamine: analysis and report

1 reference

12 December 2020

Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness

1 reference

12 December 2020

10.2165/00003088-199500291-00003

Identifiers

DOI

0 references

Dimensions Publication ID

1000285125

0 references

Fatcat ID

release_qsc2sswm6bhlhklmuqwtgaxq2q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qsc2sswm6bhlhklmuqwtgaxq2q

24 November 2022

mapped directly with Wikidata item

1 reference